Device to Be Available for Immediate Commercialization; ClinicalData From 125 Patient Pivotal Trial to Be Released at the ASAInternational Stroke Conference in New Orleans on February 22, 2008
SAN LEANDRO, Calif.--(Business Wire)--Penumbra, Inc. today announced the 510(k) clearance by the US Foodand Drug Administration of the Penumbra System, which is indicated foruse in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease within 8hours of symptom onset. Penumbra will commence the immediatecommercialization of the device in the United States.
full article >> http://www.reuters.com/article/pressRelease/idUS94969+07-Jan-2008+BW20080107
No comments:
Post a Comment